Last update 23 Jan 2025

Hangzhou Gongchu Biotechnology Co., Ltd.

Joint Venture Company | Private Company|
2018|
Zhejiang Sheng, China

Overview

Tags

Neoplasms
Nervous System Diseases
Endocrinology and Metabolic Disease
Oncolytic virus

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Top 5 Drug TypeCount
Oncolytic virus2
Top 5 TargetCount
STRIP1(striatin interacting protein 1)1
SIKE1(suppressor of IKBKE 1)1

Related

2
Drugs associated with Hangzhou Gongchu Biotechnology Co., Ltd.
Oncolytic vaccinia virus (Hangzhou Gongchu Biotechnology)
Target
STRIP1
Mechanism
STRIP1 inhibitors
Active Org.
Hangzhou Gongchu Biotechnology Co., Ltd.
Originator Org.
Hangzhou Gongchu Biotechnology Co., Ltd.
Active Indication
High grade glioma [+10]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
CN113755455
Patent Mining
Target
SIKE1
Mechanism-
Active Org.
Hangzhou Gongchu Biotechnology Co., Ltd.
Originator Org.
Hangzhou Gongchu Biotechnology Co., Ltd.
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
4
Clinical Trials associated with Hangzhou Gongchu Biotechnology Co., Ltd.
NCT06660056
/ RecruitingPhase 1
A Phase I Study Evaluating the Safety, Tolerability, Biodistribution and Shedding of Oncolytic Vaccinia Virus GC001, Pharmacodynamics, Immunogenicity, and Antitumor Activity of the Virus in Patient With Recurrent or Progressive Gliomas
CTR20231135
/ RecruitingPhase 1
一项评估 GC001 溶瘤痘苗病毒注射液在晚期实体瘤患者中的安全性、耐受性、病毒的生物分布和脱落、药效学、免疫原性和抗肿瘤活性的 I 期临床研究
[Translation] A Phase I study evaluating the safety, tolerability, viral biodistribution and shedding, pharmacodynamics, immunogenicity, and antitumor activity of GC001 oncolytic vaccinia virus injection in patients with advanced solid tumors
NCT06508307
/ RecruitingPhase 1
A Phase I Study Evaluating the Safety, Tolerability, Biodistribution and Shedding of the Virus, Pharmacodynamics, Immunogenicity, and Antitumor Activity of GC001 Oncolytic Vaccinia Virus Injection in Patient With Advanced Solid Tumors.
100 Clinical Results associated with Hangzhou Gongchu Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Hangzhou Gongchu Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Hangzhou Gongchu Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Hangzhou Gongchu Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
Phase 1 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Oncolytic vaccinia virus (Hangzhou Gongchu Biotechnology)
 ( STRIP1 )		Uterine Cervical Cancer
More
Phase 1
CN113755455
 ( SIKE1 )		Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free